Dabigatran etexilate Terminated Phase 4 Trials for Nonvalvular Atrial Fibrillation Diagnostic

IndicationsStatusPurposePhase
TerminatedDiagnostic4
clinicaltrials.gov IdentifierTitleDrugs
NCT01546883Dabigatran's Effect on Changes in Atrial Fibrosis in Patients With Atrial Fibrillation